Financial Statements — ILAG
Balance Sheet
(in millions USD)| Metric | FY
2025 | FY
2024 | FY
2023 | FY
2022 |
|---|
| Cash & Equivalents | 0.05 | 1.28 | 0.08 | 9.17 |
| Accounts Receivable | 0.24 | 0.14 | 0.45 | 1.62 |
| Inventory | 5.39 | 5.03 | 5.03 | 4.47 |
| Total Current Assets | 6.82 | 8.82 | 12.10 | 16.02 |
| Property, Plant & Equipment | 1.38 | 4.93 | 5.67 | 5.13 |
| Total Non-current Assets* | 1.66 | 5.62 | 6.18 | 5.79 |
| Total Assets | 8.48 | 14.44 | 18.28 | 21.80 |
| Accounts Payable | 0.50 | 0.25 | 0.32 | 0.40 |
| Total Current Liabilities | 3.46 | 1.42 | 1.39 | 1.81 |
| Long-term Debt | 1.58 | 0.42 | 0.46 | 0.62 |
| Total Non-current Liabilities | 0.17 | 0.38 | 0.49 | 0.54 |
| Total Liabilities | 3.63 | 1.80 | 1.88 | 2.35 |
| Retained Earnings | (30.18) | (10.83) | (7.14) | (3.64) |
| Total Stockholder Equity* | 4.86 | 12.64 | 16.40 | 19.45 |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | FY
2025 | FY
2024 | FY
2023 | FY
2022 |
|---|
| Total Revenue | 4.49 | 7.51 | 6.44 | 12.16 |
| Cost of Revenue | 3.97 | 5.83 | 5.46 | 9.96 |
| Gross Profit | 0.13 | 1.31 | 0.63 | 2.20 |
| Research & Development | 1.65 | 0.65 | -- | -- |
| Selling, General & Admin | 14.76 | 3.40 | 4.44 | 4.21 |
| Total Operating Expenses | 19.48 | 5.18 | 4.53 | 4.46 |
| Operating Income | (19.35) | (3.87) | (3.89) | (2.27) |
| Pretax Income | (19.32) | (3.61) | (3.45) | (1.66) |
| Tax Provision | 0.03 | 0.08 | 0.06 | 0.00 |
| Net Income | (19.35) | (3.69) | (3.50) | (1.66) |
| Basic EPS | (9.50) | (0.20) | (0.19) | (0.11) |
| Diluted EPS | (9.50) | (0.20) | (0.19) | (0.11) |
Cash Flow Statement
(in millions USD)| Metric | FY
2025 | FY
2024 | FY
2023 | FY
2022 |
|---|
| Operating Cash Flow | (2.43) | (3.04) | (3.16) | (4.17) |
| Capital Expenditures | 0.02 | 0.12 | 1.36 | 4.18 |
| Free Cash Flow* | (2.45) | (3.16) | (4.52) | (8.35) |
| Investing Cash Flow | -0.00 | (0.12) | (1.36) | (4.18) |
| Financing Cash Flow | 1.80 | (0.04) | (0.15) | 17.40 |
* Derived from reported values
